Laser-made SERS chip sorts cells with 96.2% accuracy
Researchers in China and Japan developed a femtosecond laser-fabricated microfluidic chip that uses surface-enhanced Raman scattering and deep learning to identify and sort single cells without labels. The system reached 96.2% cancer-cell identification accuracy and could improve non-invasive cell sorting for diagnostics and precision medicine.
Why it matters: - The new chip targets a major bottleneck in precision biomedicine: isolating rare or mixed cells without fluorescent or magnetic labels. - Better label-free sorting could improve cancer research, drug screening, gene-expression analysis, and future clinical diagnostics. - The approach also matters because cell-sorting accuracy directly affects downstream single-cell analysis and cell-based therapies.
What happened: - Researchers developed a microfluidic surface-enhanced Raman scattering, or SERS, chip for deep-learning-assisted, label-free single-cell identification and sorting. - The work was made available online July 29, 2026, in the Early View section of Opto-Electronic Advances. - The team was led by Professor Koji Sugioka and Dr. Shi Bai from RIKEN's Advanced Laser Processing Research Team. - The chip was built using femtosecond laser processing. - In proof-of-concept tests, the device sorted cancer and non-cancer cells in a Y-shaped microchannel.
The details: - The chip uses plasmonic ring-shaped nanostructure arrays formed by laser near-field reduction of gold ions. - The fabrication method introduces cetyltrimethylammonium bromide into the precursor solution. - The gold nanoparticles are about 28 nm in size. - The number of gold nanoparticles and their gaps in each ring depend on reduction time, which affects SERS performance. - Raman mapping showed ultrahigh spatially uniform Raman enhancement, with a relative standard deviation of 2%. - The chip achieved an experimentally confirmed spatial resolution of about 185 nm. - That spatial resolution improved cell-identification accuracy from 75% to 96.2%. - The researchers said the high spatial resolution was essential for deep-learning label-free cell identification. - The preliminary sorter separated cells without biomarker or Raman-tag labeling. - The original paper is titled "Deep-learning-assisted label-free single-cell identification and sorting using femtosecond laser fabricated microfluidic surface-enhanced Raman scattering (SERS) chips with plasmonic ring-shaped nanostructure arrays." - The paper was published in Opto-Electronic Advances under DOI 10.29026/oea.2026.260071. - Opto-Electronic Advances launched in March 2018 and is an open-access, peer-reviewed SCI journal indexed in SCI, EI, and Scopus. - The journal's website is More information.
Between the lines: - The result points to a key tradeoff in label-free sorting: deep learning can boost performance, but the sensing hardware still needs enough sensitivity and spatial resolution to produce reliable inputs. - The reported jump from 75% to 96.2% suggests the chip design itself, not just the algorithm, was a major driver of performance. - The findings also underscore that SERS-based systems may be most useful when the substrate, cell type, and detection workflow are carefully matched.
What's next: - The researchers said the platform could inform future non-invasive, efficient cell-sorting techniques. - The next step is likely broader validation across more cell types and more complex biological samples. - If that testing holds up, the chip could move closer to clinical diagnostics and precision medicine use cases.
The bottom line: - A laser-fabricated SERS chip paired with deep learning delivered high-precision, label-free cell sorting and showed that spatial resolution is a key factor in accurate single-cell identification.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Healthcare Reporter Japan
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.